Pharma needs to utilise the latest ... outside parties across the multiple tiers of your supply chain? Following other industries, like high-tech and consumer goods, pharma companies need to ...
The assessment by DA Davidson reflects the ongoing battle for retail supremacy, where efficiency and speed are paramount. The ...
Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback